Table 2 Patient characteristics (N = 20)
Age (years) | Median, range | 35 (19–67) |
|---|---|---|
Sex | Male/female | 15/5 |
Disease duration (years) | Median, range | 10 (1–22) |
Disease location | L1/L2/L3a | 6/0/14 |
CDAI | Median, range | 142 (60–324)b |
History of surgery (%) | 70.0% (14/20) | |
Medication (%) | Mesalazine | 80.0% (16/20) |
Elemental diet | 70.0% (14/20) | |
Anti-TNF agents | 55.0% (11/20) | |
Thiopurines | 25.0% (5/20) | |
Ustekinumab | 10.0% (2/20) |